Schedule 13D ownership disclosure

TETRALOGIC PHARMACEUTICALS COR

Security class unavailable · CUSIP: 88165U109

Event date: 2016-11-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-16-008820
Form type
SC 13D
Filer
HIGHBRIDGE CAPITAL MANAGEMENT LLC
CIK
CIK 919185
Filed
Nov 14, 2016
Reporting period
Nov 02, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub